BioNexus Gene Lab (BGLC) SEC Filings & 10K Form

$0.59
+0.00 (+0.15%)
(As of 04/26/2024 08:52 PM ET)

Recent BioNexus Gene Lab SEC Filings

DateFilerForm TypeView
04/18/2024
12:44 PM
BioNexus Gene Lab (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/16/2024
12:00 PM
BioNexus Gene Lab (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/28/2024
2:59 PM
BioNexus Gene Lab (Filer)
Form NT 10-K
02/29/2024
4:16 PM
BioNexus Gene Lab (Filer)
Form DEF 14C
01/23/2024
6:55 AM
BioNexus Gene Lab (Subject)
Erayak Power Solution Group Inc. (Filed by)
Form SC 13G
11/20/2023
4:10 PM
BioNexus Gene Lab (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/14/2023
10:54 AM
BioNexus Gene Lab (Filer)
Form NT 10-Q
11/03/2023
9:55 AM
BioNexus Gene Lab (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2023
11:14 AM
BioNexus Gene Lab (Filer)
Form 8-K/A
10/17/2023
10:46 AM
BioNexus Gene Lab (Subject)
Wong Chan Chong (Filed by)
Form SC 13G
10/16/2023
9:04 AM
BioNexus Gene Lab (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/11/2023
9:02 AM
BioNexus Gene Lab (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/04/2023
2:55 PM
BioNexus Gene Lab (Issuer)
Leong Wei Li (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/04/2023
2:55 PM
BioNexus Gene Lab (Issuer)
Yeoh Sook Keng (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/04/2023
2:56 PM
BioNexus Gene Lab (Issuer)
Fong Yeat Min (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/04/2023
2:56 PM
BioNexus Gene Lab (Issuer)
Teoh Boon Teong (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/04/2023
2:56 PM
BioNexus Gene Lab (Issuer)
Lin Chai Ping (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/04/2023
2:57 PM
BioNexus Gene Lab (Issuer)
Yew Chak Hua (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/04/2023
2:57 PM
BioNexus Gene Lab (Issuer)
Yap Chee Keong (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/04/2023
2:57 PM
BioNexus Gene Lab (Issuer)
Wong Yee Meng (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/04/2023
2:54 PM
BioNexus Gene Lab (Issuer)
Fong Teng Fook (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/04/2023
2:55 PM
BioNexus Gene Lab (Issuer)
Liong Tai Tan (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/07/2023
10:17 AM
BioNexus Gene Lab (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/16/2023
10:26 AM
BioNexus Gene Lab (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/14/2023
10:55 AM
BioNexus Gene Lab (Filer)
Form NT 10-Q
07/24/2023
4:28 PM
BioNexus Gene Lab (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/21/2023
2:37 PM
BioNexus Gene Lab (Filer)
Form 424B4
07/20/2023
11:28 AM
BioNexus Gene Lab (Filer)
Form CERT
07/20/2023
10:29 AM
BioNexus Gene Lab (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/19/2023
11:15 PM
BioNexus Gene Lab (Filer)
Form EFFECT
07/19/2023
1:35 PM
BioNexus Gene Lab (Filer)
Form 8-A12B
07/14/2023
6:20 PM
BioNexus Gene Lab (Filer)
Form S-1/A
05/17/2023
8:07 AM
BioNexus Gene Lab (Filer)
Form DEF 14C
05/09/2023
10:39 AM
BioNexus Gene Lab (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:BGLC) was last updated on 4/29/2024 by MarketBeat.com Staff

From Our Partners